Arkansas Cardiology consultants
Cardiology
Abdul Ezeldin practices Cardiology. He received awards:"CMS Meaningful Use Stage 1 Certification", "FSCAI FASE FSVM FASNC" and "Fellow (FACC)". Abdul Ezeldin is a published physician as well. He has 2 publications published. The latest was: Wolff-Parkinson-White syndrome in previously undiagnosed Ebstein's anomaly. Abdul K. Ezeldin accepts all Medicare patients.
Publications
Schools
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- Old Surety Life Insurance CompanyMedicare MCR
- Principal Life
- Qualchoice PPO
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- FSCAI FASE FSVM FASNC
- Fellow (FACC)
Education
-
University of Pennsylvania
-
University of Aleppo Faculty of Medicine
Drug Facts
NPI NUMBER |
|
1639129133 |
NPPES Provider LastName |
|
EZELDIN |
NPPES Provider FirstName |
|
ABDUL |
NPPES Provider ZIPCode |
|
716036962 |
NPPES Provider State |
|
AR |
Specialty Description |
|
Cardiology |
Total Claim Count |
|
4221.0 |
Distinct Opioid Count |
|
1.0 |
Opioid Claim Count |
|
25.0 |
Percent Opioid Claims |
|
0.59 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1639129133 |
Last Name Of The Provider |
EZELDIN |
First Name Of The Provider |
ABDUL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog